Celldex Therapeutics reported $15.01M in Operating Expenses for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 10105M 458M
Agenus AGEN:US $ 49.62M 10.6M
Amgen AMGN:US $ 4.63B 656M
Applied Genetic Technologies AGTC:US $ 15.11M 53K
Aptinyx Inc APTX:US $ 11.68M 1.45M
Biocept BIOC:US $ 11.4M 4.05M
Bristol Myers Squibb BMY:US $ 22.9B 13.74B
Celldex Therapeutics CLDX:US $ 15.01M 3.41M
Glaxosmithkline GSK:US 7.68B 890M
Immunogen IMGN:US $ 49.28M 14.36M
Newlink Genetics NLNK:US 7.23M 321K
Pfizer PFE:US $ 11160M 1314M
Rigel Pharmaceuticals RIGL:US $ 32.17M 1.24M
Seattle Genetics SGEN:US $ 436.31M 12.76M